19 Mar 2010 13:00
RNS Number : 8648I
Akers Biosciences, Inc.
19 March 2010
For immediate release: 19 March 2010
Akers Biosciences, Inc.
(the "Company")
Change of Adviser
Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce the appointment of Daniel Stewart & Company plc as Nominated Adviser and Broker to the Company with immediate effect.
Enquiries:
Thomas A. Nicolette
President and CEO
Tel. +1 856 848 8698
Ben Simons
M: Communications
Tel. +44 (0)20 7920 2340
Emma Earl or Simon Leathers
Daniel Stewart & Co.
Tel. +44 (0)20 7776 6550
This information is provided by RNS
The company news service from the London Stock Exchange
AKR.L (AKR)